Liang Dong

China Railway Fifth Survey and Design Institute Group — China

Medicine · Health Sciences

11h-index419citations21works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(7), RNA modifications and cancer(3), Protein Tyrosine Phosphatases(3), Asthma and respiratory diseases(2), Chronic Obstructive Pulmonary Disease (COPD) Research(2)

Publications21 total

Considering tectonic uplift in landslide susceptibility assessment using MaxEnt model: a case study of Trishuli River watershed
Environmental Earth Sciences·2025· 2 cited
3D-printed nanoplasmonic device with super-hydrophobic sample concentrator for biosensing
2024
Natural Fractures and Their Contribution to Natural Gas Migration and Accumulation in Marine Carbonate Reservoirs: Lower Triassic Feixianguan Formation, Northeast Sichuan Basin, China
Sustainability·2023· 3 citedOpen Access
NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15
Precision Clinical Medicine·2023· 9 citedOpen Access
Protein tyrosine phosphatase <scp>PTPL1</scp> suppresses lung cancer through Src/<scp>ERK</scp>/<scp>YAP1</scp> signaling
Thoracic Cancer·2022· 6 citedOpen Access
Dexlansoprazole prevents pulmonary artery hypertension by inhibiting pulmonary artery smooth muscle cell to fibroblast transition.
PubMed·2022· 1 citedOpen Access
PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT
Acta Pharmacologica Sinica·2021· 24 citedOpen Access
Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling
Acta Pharmacologica Sinica·2020· 18 citedOpen Access
Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs
Acta Pharmacologica Sinica·2019· 71 citedOpen Access
Interleukin-18 binding protein attenuates lipopolysaccharide-induced acute lung injury in mice via suppression NF-κB and activation Nrf2 pathway
Biochemical and Biophysical Research Communications·2018· 16 cited
Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world
The Clinical Respiratory Journal·2018· 29 citedOpen Access
Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
Frontiers in Pharmacology·2018· 21 citedOpen Access
Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report
BMC Pulmonary Medicine·2018· 9 citedOpen Access
Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report
Oncology Letters·2017· 17 citedOpen Access
Treatment of Pulmonary Arterial Hypertension Using Initial Combination Therapy of Bosentan and Iloprost
Respiratory Care·2017· 17 citedOpen Access
Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice
Shock·2016· 97 citedOpen Access
1α,25-Dihydroxyvitamin D3 Induces Neutrophil Apoptosis through the p38 MAPK Signaling Pathway in Chronic Obstructive Pulmonary Disease Patients
PLoS ONE·2015· 28 citedOpen Access
Research situation between Th17 cells and chronic obstructive pulmonary disease
Chinese Journal of Asthma·2014
Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Evidence-based Complementary and Alternative Medicine·2014· 50 citedOpen Access
Advances in diagnosis and therapy of difficult-treat asthma
Chinese Journal of Asthma·2010
page 1 of 2Next →

Frequent Co-authors

Jingwen Xia(11), Shengqing Li(11), Xiujuan Zhang(7), Mengjie Niu(5), Gulinuer Wumaier(5), Yi Gong(4), Ning Zhu(4), You‐Zhi Zhang(4), Ning Zhu(4), Yuanyuan Zhang(4), Liying Fang(3), Yaqin Chai(3), Chengwei Li(3), Zhiwei Yang(2), Shengli Zhang(2), Xiaomin Wei(2), Peng Zhang(2), Haihua Yang(2), Jian He(2), Xiaodong Chen(2)